We are monitoring the impact of COVID-19 on Latin America Non-Invasive Cancer Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Latin America Non-Invasive Cancer Diagnostics Market Research Report - Segmented By Therapeutics, Techniques & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis on Size, Share, Trends, Growth, Forecast | 2022 to 2027

Published: January, 2022
ID: 5369
Pages: 145

Latin America Non-Invasive Cancer Diagnostics Market Size & Growth (2022 to 2027):

As Per the Report, the Size of the Latin America Non-Invasive Cancer Diagnostics Market was valued at USD 10.31 billion in 2022 and estimated to grow at a CAGR of 8.11%, to reach USD 15.23 billion by 2027 during the forecast period 2022 to 2027.

A medical procedure is referred to as non- invasive when there is a slight incision in the body in diagnosis. There are various non- invasive diagnostics methods which range from simple observation to specialized surgery.

The significant drivers are increasing incidence of cancer due aging, and increasing awareness about early cancer diagnosis. Advancements in cancer detection techniques is also expected to drive the market over the forecast period. However, high cost of treatment is a major restraint limiting this industry.

This research report on the Latin America Non-Invasive Cancer Diagnostics Market has been segmented and sub-segmented into the following categories

By Therapeutics:

  • Blood cancer
  • Breast Cancer
  • Lung Cancer
  • Solid tumors

By Techniques:

  • Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • the Rest of Latin America

On the basis of region, the rising focus of key players on enhancing their market presence across the globe is estimated to encourage the growth of the market in the Latin America regions.

Noteworthy Companies leading the Latin America Non-Invasive Cancer Diagnostics Market Profiled in the Report are Precision Therapeutics, Laboratory Corporation of America Holdings (LabCorp), BIOVIEW Inc.,   Affymetrix Inc., AVIVA Biosciences Corporation, A&G Pharmaceutical, Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation and Gen-Probe Incorporated.

1. Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemiology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Techniques                 

         5.1.1 Introduction           

         5.1.2 Clinical Chemistry 

         5.1.3 Immunochemistry/Immunoassay 

         5.1.4 Molecular Diagnostics        

         5.1.5 Other Clinical Instruments

         5.1.6  Y-o-Y Growth Analysis, By Techniques       

         5.1.7  Market Attractiveness Analysis, By Techniques     

         5.1.8  Market Share Analysis, By Techniques       

                5.2 Type       

         5.2.1 Introduction           

         5.2.2 Breast Cancer        

         5.2.3 Blood cancer          

         5.2.4 Lung Cancer            

         5.2.5 Solid tumors           

         5.2.6 Others      

         5.2.7 Y-o-Y Growth Analysis, By Type     

         5.2.8 Market Attractiveness Analysis, By Type   

         5.2.9 Market Share Analysis, By Type     

6. Geographical Analysis

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Techniques

  6.1.3.3 By Type

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Techniques

  6.1.4.3 By Type

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Techniques

  6.1.5.3 By Type

                6.2 Brazil      

                6.3 Mexico  

                6.4 Argentina

                6.5 Rest of Latin America      

7. Strategic Analysis                

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                 

                8.1 AVIVA Biosciences Corporation  

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Affymetrix Inc.   

                8.3 A&G Pharmaceutical       

                8.4 BIOVIEW Inc.      

                8.5 Digene Corporation                

                8.6 Gen-Probe Incorporated                      

                8.7 Laboratory Corporation of America Holdings (LabCorp)   

                8.8 Precision Therapeutics   

                8.9 Quest Diagnostics Incorporated

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures       

  1. Latin America Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2022 - 2027 ( USD Billion )
  2. Latin America Clinical Chemistry Market By Region, From 2022 - 2027 ( USD Billion )
  3. Latin America Immunochemistry/Immunoassay Market By Region, From 2022 - 2027 ( USD Billion )
  4. Latin America Molecular Diagnostics Market By Region, From 2022 - 2027 ( USD Billion )
  5. Latin America Other Clinical Instruments Market By Region, From 2022 - 2027 ( USD Billion )
  6. Latin America Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2022 - 2027 ( USD Billion )
  7. Latin America Breast Cancer Market By Region, From 2022 - 2027 ( USD Billion )
  8. Latin America Blood cancer Market By Region, From 2022 - 2027 ( USD Billion )
  9. Latin America Lung Cancer Market By Region, From 2022 - 2027 ( USD Billion )
  10. Latin America Solid tumors Market By Region, From 2022 - 2027 ( USD Billion )
  11. Latin America Others Market By Region, From 2022 - 2027 ( USD Billion )
  12. Brazil Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2022 - 2027 ( USD Billion )
  13. Brazil Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2022 - 2027 ( USD Billion )
  14. Argentina Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2022 - 2027 ( USD Billion )
  15. Argentina Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2022 - 2027 ( USD Billion )
  16. Mexico Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2022 - 2027 ( USD Billion )
  17. Mexico Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2022 - 2027 ( USD Billion )
  18. Rest of Latin America Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2022 - 2027 ( USD Billion )
  19. Rest of Latin America Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample